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Streszczenie
Wstęp: Operacje nadnerczy stały się obecnie najszybciej rozwijającą się dziedziną chirurgii endokrynologicznej. Wpływ na to, poza roz-
wojem technik chirurgicznych i wprowadzeniem metody laparoskopowej jako rutynowego leczenia operacyjnego zmian w nadnerczach,
miały też inne czynniki. Należą do nich: rozwój diagnostyki endokrynologicznej i obrazowej oraz poznanie etiologii i zrozumienie wza-
jemnych uwarunkowań hormonalnych zmian w obrębie nadnerczy.
Materiał i metody: Na podstawie doświadczenia Kliniki Chirurgii Ogólnej, Naczyniowej i Transplantacyjnej WUM, w której w latach
1997–2009 wykonano 711 adrenalektomii (529 metodą laparoskopową, 182 metodą klasyczną) przedstawiono aktualne metody operacji
nadnerczy, kwalifikacji oraz wskazań do leczenia operacyjnego.
Wyniki. Laparoskopowa adrenalektomia, potwierdzając swoje bezpieczeństwo i korzyści, zyskała aprobatę środowiska
Medycznego, stając się podstawowym sposobem leczenia operacyjnego.
Wnioski.
1. Adrenalektomia wideoskopowa/laparoskopowa stała się operacją referencyjną w leczeniu zmian nadnerczowych.
2. Ścisła wielodyscyplinarna współpraca lekarzy biorących udział w leczeniu chorych ze zmianami nadnerczowymi spowodowała,
że operacje nadnerczy stały się obecnie najszybciej rozwijającą się dziedziną chirurgii endokrynologicznej.
(Endokrynol Pol 2010; 61 (6): 716–722)
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Abstract
Introduction: Nowadays operations of adrenal glands became the fastest-expanding field of the endocrine surgery. Besides the develop-
ment of surgical techniques and introduction of laparoscopic method as a routine operating treatment of adrenal lesions, also other factors
like a development of the endocrinological and imaging diagnosis together with the knowledge of etiology and understanding of hormo-
nal interactions of the arenal glands have contributed to it.
Material and methods: Based on experience of the Department of General, Vascular and Transplant surgery WUM where between
1997–2009 711 adrenalectomies were carried out (529 laparoscopic and 182 classical) current methods of adrenal operation, qualifications
and indications were presented.
Results: Laparoscopic adrenalectomy confirming it’s safety and benefits has gained the approval of the medical fraternity and became the
main method of surgical treatment.
Conclusions:
1. Videoscopic/laparoscopic adrenalectomy became the recommended operation in the treatment of adrenal lesions.
2. Close multidisciplinary cooperation of doctors participating in the treatment of patients with adrenal pathology has made the adrenal
gland surgery the most rapidly developing field of the endocrine surgery.
(Pol J Endocrinol 2010; 61 (6): 716–722)
Key words: adrenal tumors, operations of the adrenal gland, laparoscopic adrenalectomy
Introduction
Surgery is the principal element of management of ad-
renal tumours detected by imaging studies. In pha-
eochromocytoma, surgery is the treatment of choice,
the only method that gives the patient a chance of cure
and a method that makes it possible to avoid dangero-
us cardiovascular complications [1–4]. There has been
an increasing change in therapeutic approach due to
the recent dynamic progress in endocrine diagnostics,
a better understanding of the pathophysiology of en-
docrine disorders, and progress in the imaging evalu-
ation of adrenal glands. This is also markedly reflected
in the tactics and assumptions of surgical treatment,
particularly since the introduction of microinvasive la-
paroscopic surgery in routine practice [5].
The beginnings of adrenal surgery date back to the
late 19th century, when J.K. Thornton performed the
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first documented resection of an adrenal tumour in 1889.
In 1926, independently, Cesar Roux in Switzerland and
Charles Mayo in the US performed surgery for pha-
eochromocytoma [2].
In this initial period of surgery the effect of adrenal
tumours on the body was unclear and no uniform ter-
minology was used. The role of surgery was therefore
limited to resection of a tumorous adrenal gland. It was
not until a better understanding of the aetiology and
endocrine interrelationships was gained that the tac-
tics of surgical management and surgical techniques
could be developed [6].
The recognition of the metabolic nature of adrenal
disorders has been the factor determining the possibili-
ties of surgical treatment. The discovery and clinical
application of cortisone in 1950 should therefore be con-
sidered the beginning of modern endocrinology and
modern endocrine surgery. This was a breakthrough
in our understanding of the pathophysiology of adre-
nal disorders, which ten years later led to the formula-
tion of a hypothesis whereby the systemic homoeosta-
sis is jointly regulated by the nervous system and the
endocrine system (neurohormones) [5]. This, in turn,
made it possible to change the tactics of surgical mana-
gement and broadened the scope of endocrine surgical
procedures, especially adrenal surgery. The scope of
adrenal resection became increasingly dependent on the
intraoperative assessment, which necessitated visuali-
sation of both glands.
The second half of the 20th century was a period of
dynamic development for endocrine surgery, allowing
surgeons to resect the gland to the extent necessary to
restore hormonal balance, and to intervene before se-
condary systemic changes (preclinical endocrine syn-
dromes, incidentaloma, ACTH-dependent hypercorti-
solaemia) could develop [5, 7].
The development of surgical methods is the result
of attempts to use the least traumatogenic techniques
and to perform the so-called targeted operations invo-
lving only the gland or the tumour responsible for
a given pathology. This was possible thanks to advan-
ces in anatomy, physiology, and pathophysiology, pro-
gress in imaging techniques (ultrasound, scintigraphy,
computed tomography, magnetic resonance imaging,
positron emission tomography), and methods of resto-
ring endocrine balance in the preoperative period. All
these factors have contributed to the fact that adrenal
surgery has now become the fastest growing area of
endocrine surgery [8–11].
Currently the surgeon’s intervention is not limited
to a simple removal of the tumour but includes a well-
informed resection taking into consideration the known
endocrine implications. This state of affairs may be sum-
marised by paraphrasing the Polish writer Bolesław
Prus: “The difference between a good and a bad writer
is as follows: a bad writer writes what he knows, while
a good one knows what he writes”.
Methods of adrenal surgery
It seems that as far as the history of surgical techniques
is concerned, the current possibilities of treatment of
adrenal lesions have been principally influenced by
three events. Firstly, by the report of simultaneous un-
covering and operation of both adrenals through ap-
proaches along the spine, as described by H.H. Young
in 1936, secondly by the presentation of the benefits of
the transperitoneal approach in 1955 by Aird, and, thir-
dly, almost a century after the first documented adre-
nalectomy, by laparoscopic adrenal resection, as per-
formed by L. Snow in 1991 [2, 5]. These three events
have had a fundamental effect on the tactics of surgical
treatment. The surgeon can now not only select the
approach to the adrenal gland but also the surgical tech-
nique: classical or laparoscopic. The latter, through wi-
despread acceptance, has had a tempestuous growth
leading to the development, within the method, of com-
parable approaches to those in classical surgery. The
principles and aims of surgical treatment have rema-
ined the same. The surgical approach depends on the
cause of the pathology, tumour size, performance sta-
tus, and the surgeon’s experience [12].
The classical approaches in adrenal surgery inclu-
de: anterior transperitoneal approach, abdominothora-
cic approach, anterolateral thoracic approach with in-
cision of the diaphragm, lateral extraperitoneal appro-
ach, and posterior approach through the 10th, 11th, and
12th ribs. The most commonly used approaches at pre-
sent are the anterior transperitoneal approach and the
lateral or posterior extraperitoneal approach. The ante-
rior transperitoneal approach is recommended for bila-
teral or ectopic lesions and for repeat surgery for pha-
eochromocytoma and invasive tumours. The problem
with this approach is the considerable extent of the cu-
taneous incision affecting the patient’s comfort during
the postoperative period and wound healing as a re-
sult of its reduced resistance to infection. The posterior
approach form the lumbar muscles (extraperitoneal
approach) is better tolerated by patients. There is a lo-
wer rate of infection with this approach. The thoraco-
abdominal approach and the anterolateral thoracic ap-
proach with incision of the diaphragm are rarely utili-
sed and are indicated only in large malignant adrenal
tumours [12, 13].
Laparoscopy has become the reference method in
surgical management of adrenal glands despite conti-
nuing to raise certain objections in the case of malignant
tumours. Nevertheless, numerous studies confirm that
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the method allows one to respect the principles of on-
cologic surgery and to remove invasive tumours. For
this reason the different variations of microinvasive
adrenal resection have become an integral part of en-
docrine surgery and are considered the fundamental
method of treatment. The approaches used in video-
assisted adrenal surgery are summarised in Table I [8].
Each of the four methods differs in terms of appro-
ach, which is associated with various technical aspects
of the procedure, although all of them share the same
benefits of microinvasive surgery, namely a lower in-
juriousness resulting from a lower tissue traumatisa-
tion and a better intraoperative anatomical visualisa-
tion translating into a higher peri- and postoperative
comfort perceived by the patient. This leads to shorter ho-
spitalisation, a more rapid recovery and resumption of life
and professional activities, and a lower severity of posto-
perative pain. Another important factor is the cosmetic
effect in the form of a smaller postoperative scar [10].
The most common laparoscopic approach, used in
about 85% of adrenalectomies, is the lateral transperi-
toneal approach. It enables the surgeon to perform, be-
fore tissue preparation, a thorough assessment of the
adrenal gland, to locate the tumour and its surroun-
ding tissues, and carry out intraperitoneal diagnostics
[1, 5, 8, 11].
As in the classical method, laparoscopy enables, ac-
cording to the indications, bilateral simultaneous adre-
nalectomy (pheochromocytoma) or two-stage (syndro-
mes associated with hypercortisolaemia) to be perfor-
med. Thanks to the increasing amount modern, techni-
cally reliable equipment, eliminating the inconvenience
of laparoscopy (lack of the sense of touch), it is feasible
to use sparing resection of the adrenal to preserve the
adrenocortical function.
As a result, it is possible to avoid the use of perma-
nent substitution therapy in patients who have under-
gone bilateral adrenalectomy. The indications for lapa-
roscopy are, first of all, hereditary multiple endocrine
neoplasia syndromes in which pheochromocytoma is
one of their components. The opportunity to use intra-
operative ultrasonography is very helpful in intraope-
rative decision making in this technique [4, 15, 16]. This
allows the avoidance and resolution of problems asso-
ciated with the sparing adrenalectomy, such as asses-
sment of the line of resection, confirmation of the le-
sion resection, and the existence of neoplastic invasion.
Evaluation of the resection line defines radicality of
tumour excision and the borderline of normal remaining
adrenal cortex. The size of the operated tumour has an
impact on this. Most favourable conditions for leaving
the adrenal cortex well-supplied with blood have le-
sions with a diameter of no more than 2 cm. Relapses in
classic sparing operations occur in 33% of patients with
MEN II syndrome and in 15% with von Hippel Lindau
syndrome [17–19].
Confirmation of lesion resection ensures the elimi-
nation of catecholamine excretion as well. In addition
to the central tumour satellite lesions unrecognized in
imaging studies may coexist (Fig. 1)
The last problem is the evaluation of neoplastic inva-
sion. Assessment and diagnosis of malignant pheochro-
Table I. Videoscopic approaches in adrenal surgery
Tabela I. Rodzaje dostępów wideoskopowych w operacjach nadnerczy
Videoscopic access to the adrenal  Authors
Transperitoneal anterior Bońjer, Linos, Takeda Fernandez-Cruz
Laparoscopic
Transperitoneal lateral Higashihara, Gagner, Marescaux, Brunt, Jacobs
Laparoscopic
Retroperitoneal lateral Mercan, Bońjer, Heintz, Fernandez-Cruz
Retroperitoneal posterior Duh, Baba, Smith
Figure 1. Bilateral pheochromocytoma: centre tumour with
numerous satellite nodules
Rycina 1. Obustronne guzy chromochłonne: guz centralny z li-
cznymi guzkami satelitarnymi
Guzek
centralny
Guzki
satelitarne
Guz nadnercza
lewego Guz nadnercza
prawego
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mocytoma is always a big clinical and pathomorpholo-
gical problem. Pheochromocytoma is malignant in abo-
ut 10% of cases (from 2.5–26%). Still the only sure cor-
firmation of malignancy can give the presence of meta-
stases to the lymph nodes and distant organs, which in
physiological conditions do not contain chromaffin tis-
sue. Infiltration of surrounding tissues and vessels does
not directly indicate a malignant process. Factors that
may suggest it are: young age, multiple lesions, extra-
adrenal location (30–40%), tumour size more than 6 cm
(although there is no threshold increasing the risk of
malignancy), only dopamine-secreting tumours, and
persistent postoperative hypertension. Another factor
may also be the presence, of disease recurrence or re-
lapse after the operation. After classical surgery, recur-
rence was found in 6–8% of patients.
According to many authors, only after 15 years of
lack of recurrence following adrenalectomy due to phe-
ochromocytoma can confirmation of the effectiveness
of operations and exclusion malignancy be made. Spa-
ring adrenalectomy results show no difference in the
effectiveness of preservation of adrenal function, no
matter if the adrenal vein is ligated or not [20, 21].
Qualification for adrenalectomy
Prior to the operation and the selection of surgical techni-
que an accurate diagnosis should be determined. It is ne-
cessary to answer the question whether the observed le-
sion is or is not hormonally active; in the absence of activi-
ty, whether it is a benign or malignant; and if it is mali-
gnant, whether it is a primary or metastatic lesion. In every
case it is desirable to determine the location of the tumo-
ur. In a situation of increased secretion of hormones, the
preoperative preparation of patients is necessary:
— changes related to hypercortisolaemia — the abso-
lute inhibition of excessive secretion of cortisone —
steroidogenesis inhibitors;
— primary hyperaldosteronism — correction of the le-
vel of potassium in serum and normalization of blo-
od pressure;
— pheochromocytoma — required normalization of
blood pressure by the administration for 10–21 days
of alpha receptor blocking agents and additional
consideration of beta receptor blockade.
The preparation of pheochromocytoma is conside-
red correct if blood pressure in the supine position abo-
ve 160/90 mm Hg for 48 hours and orthostatic hypoten-
sion below 80/45 mm Hg is not found, and in addition,
in ECG, if changes in the ST-T segment and T wave re-
versal for at least two weeks are not found, as well as
premature beats - no more than one premature ventri-
cular contraction every 5 minutes [22].
In incidentaloma type tumours cancer, metastases
to the adrenal gland and increased secretion should be
ruled out. The surgical problem here is that the only
reliable confirmation of malignant incidentaloma is gi-
ven by histopathological examination performed after
surgery. It is known that tumours removed in the early
stages have a better prognosis than those removed at a
more advanced stage. The prognosis after cancer dia-
gnosis depends on the local tumour advancement at
the time of diagnosis and the radicality of tumour re-
section during the first operation. Therefore, the ope-
rated tumour should be removed without damaging the
capsule together with the entire gland and the surro-
unding adipose tissue [23]. Also, during the observa-
tion of the incidentaloma, not qualified for surgical tre-
atment initially, any clinical change should dictate the
type of surgery. Based on recent trends, this follow-up
period should be four years. After this period, if no chan-
ges in phenotype of the tumour are noticed, observa-
tion can be discontinued [9].
The risk of malignancy for hormonally inactive tumo-
urs (incidentaloma) is estimated at about 4–5%. If the dia-
meter exceeds 4 cm, the risk increases in percentage and
gradually increases with size. For tumours with a diame-
ter above 4 cm, this risk is assessed at about 10%; for tu-
mours larger than 6 cm it is 25–98%. Therefore, during
qualification of lesions without hormonal activity, the ba-
sic criterion for surgical treatment remains the size of the
tumour. The cutoff point is accepted at 4 cm [24, 25]. In
some centres, since the introduction of laparoscopic adre-
nalectomy as a treatment method for adrenal lesions, tu-
mours > 3 cm are eligible for surgery in young people
with low-risk, and > 5 cm in elderly patients with conco-
mitant diseases of other systems and organs [26].
Indications for adrenalectomy
Currently, in the presence of the two methods (classi-
cal and videoscopic-laparoscopic) of operation perfor-
med on adrenal glands, the range and the purpose of
operation have not changed. Only the surgical access
has been changed for the comfort of patients. Based
upon experience confirmed by numerous clinical stu-
dies, classical surgery should remain the only treatment
method for the so-called large tumours exceeding
10 cm, reoperation of the adrenal glands, and in the case
of invasive carcinomas with signs of malignancy detec-
ted by imaging studies (features of local invasion, lym-
phadenopathy, distant metastases) and in the absence
of an exact location — ectopic lesions [12, 13].
In other cases (hormonally active lesions, incidenta-
loma type tumours, metastatic tumours particularly
metachronous), the videoscopic/laparoscopic method
is the preferential method [23, 26]. This is also the case
in our experience (Fig. 2).
The method of qualification of a patient with adre-
nal pathology is shown in Figures 3.
720
Surgical treatment of adrenal tumours Maciej Otto
SZ
K
O
LE
N
IE
PO
D
Y
PL
O
M
O
W
E
Adrenalectomy preserving adrenocortical functions,
which enables the avoidance of substitution treatment, is
performed only in selected cases, especially in familial
multiple endocrine neoplasia syndromes. Difficulties in
the evaluation of neoplastic invasion of adrenal tumours
remain the primary limitations of indications for such ope-
rations [23, 26]. The exact tumour size indicated for lapa-
roscopic adrenalectomy/videoscopic is questionable [27].
Currently, during qualification for use of videosco-
pic techniques, the tumour size plays a decreasing role.
It is recognized that even tumours with a diameter of
up to 12 cm are not a contraindication for laparoscopic
surgery [28]. Documented advantages of minimally in-
vasive techniques are emphasized here, considering also
that the association of indications with the size depends
on the experience of the operating team and the limita-
tions of the instrumentarium [28, 29].
Another factor influencing this opinion is the obse-
rvation that imaging studies underestimate the actual
size of the tumour — in computed tomography by 16 to
47%, and in magnetic resonance imaging by 20% [30–32].
Although laparoscopic lateral transperitoneal access
is more frequently used and its larger versatility has
been emphasised,  the discussion is ongoing regarding
the advantages and disadvantages of each of the me-
thods of videoscopic access. However, the conclusions
remain unchanged: endoscopic adrenalectomy is the
method of choice, and both techniques (both trans-and
retroperitoneal) are safe and give good results [33, 34].
The controversy also applies to the application of lapa-
roscopic techniques in the surgery of malignant adre-
nal tumours. The opinion that classical adrenalectomy
remains a technique reserved for large tumours with
suspected malignancy is now challenged. Videoscopic
adrenalectomy can be performed for malignant tumo-
urs, provided the principles of the oncological radicali-
ty are preserved. Its use in these cases should be deter-
mined by the experience and skill of the surgeon, and
not by well-defined tumour size [35, 36].
Because of difficulties in the evaluation and diagno-
sis of malignancy, during videoscopic surgery the re-
moval of the adrenal tumours from the peritoneal cavi-
ty through the wound should be carried out in a lapa-
roscopic bag. In addition, it seems reasonable not to cut
the tumour unnecessarily after surgery. Sending the
intact tumour for pathomorphological testing someti-
mes facilitates difficult histological assessment of the
lesion [1, 5].
Conclusions
1. Videoscopic/laparoscopic adrenalectomy has beco-
me the recommended operation in the treatment
of adrenal lesions.
2. Close multidisciplinary cooperation of doctors par-
ticipating in the treatment of patients with adrenal
pathology has made adrenal gland surgery the most
rapidly developing field in endocrine surgery.
Rycina 2. Operated patients with adrenal pathology in the Department of General, Vascular and Transplant Surgery in the period
1997–2009
Figure 2. Operowani chorzy z patologią nadnerczy w Klinice Chirurgii Ogólnej, Naczyniowej i Transplantacyjnej WUM w okresie
1997–2009
721
Endokrynologia Polska/Polish Journal of Endocrinology 2010; 61 (6)
SZ
K
O
LE
N
IE
PO
D
Y
PL
O
M
O
W
E
References
1. Otto M, Dzwonkowski J, Jędrasik M et al. Trudności kwalifikacyjne i ope-
racyjne adrenalektomii laparoskopowej. Pol Przegl Chir 2010; 1: 64–78.
2. Otto M. Operacyjne leczenie guzów nadnerczy. In: Szczepańska-Sadow-
ska E, Sznajderman M, Januszewicz W, Januszewicz A (red.). Nadciśnie-
nie Tętnicze. Medycyna Praktyczna, Kraków 2007: 849–859.
3. Grupa Robocza Polskiego Towarzystwa Nadciśnienia Tętniczego. Wy-
tyczne dotyczące diagnostyki i leczenia chorych z guzem chromochłon-
nym. Nadciśnienie Tętnicze 2006; 10: 1–19.
4. Eisenhofer G. Pheochromocytoma: recent advances and speed bumps in
the road to further progress. J Hypertens 2006; 24: 2341–2342.
5. Otto M, Dzwonkowski J, Ciąćka T et al. Ponad 10-letnie doświa-
dczenia w leczeniu zmian nadnerczowych metodą laparoskopową
z dostępu bocznego przezotrzewnowego. Pol Przegl Chir 2008; 9:
881–894.
6. Davis CJ. A history of endoscopic. Surg Laparoscopy Endosc 1992; 2: 16–19.
7. Toniato A, Merante-Boschin I, Opocher G et al. Surgical versus conserva-
tive management for subclinical Cushing syndrome in adrenal inciden-
talomas. Ann Surg 2009; 3: 388–391.
8. Smith CD, Weber CJ, Amwerson JR. Laparoscopic adrenalectomy: new
gold standard.  World J Surg 1999; 23: 389–396.
9. Brunt LM, Moley JF. Adrenal incidentaloma. World J Surg 2001; 25: 905–913.
10. Assalia A, Gagner M. Laparoscopic adrenalectomy. Br J Surg 2004; 91:
1259––1274.
Figure 3.  Algorithm qualification of adrenal lessions for adrenalectomy
Rycina 3. Algorytm kwalifikacji zmian nadnerczowych do adrenalektomii
11. Ogilvie JB, Duh QY. New approaches to the minimally invasive treat-
ment of adrenal lesions. Cancer J 2005; 11: 64–72.
12. Miccolli P, Rafaelli M, Berti P. et al.: Adrenal surgery before and after
the introduction of laparoscopic adrenalectomy. Br J Surg 2002; 89:779–
–782.
13. Staren ED, Prinz RA. Adrenalectomy in the era of laparoscopy. Surgery
1996; 120: 706–711.
14. Kaouk JH, Matin S, Bravo EL. Laparoscopic bilateral partial adrenalecto-
my for pheochromocytoma. Urology 2002; 60: 1100–1103.
15. Jeschke K, Janetschek G, Peschel R. Laparoscopic partial adrenalectomy
in patients with aldosterone-producing adenomas: indications, techni-
que and results. Urology 2003; 61: 69–72.
16. Neumann HP, Reincke M, Bender BU. Preserved adrenocortical func-
tion after laparoscopic bilateral adrenal sparing surgery for heredity phe-
ochromocytoma. J Clin Endocrinol Metab 1999; 84: 2608–2610.
17. Neumann HP, Berger DP, Sigmund G et al. Pheochromocytomas, multi-
ple endocrine neoplasia type 2 and von Hippel-Lindau disease. N Engl
J Med 1993; 329: 1531–1538.
18. Pacak K, Ilias I, Adams KT et al. Biochemical diagnosis, localization and
management of pheochromocytoma: focus on multiple endocrine neo-
plasia type 2 in relation to other hereditary syndrome and sporadic forms
of the tumour. J Int Med 2005; 257: 60–68.
19. Walz MK. Extent of adrenalectomy for adrenal neoplasm: sparing (sub-
total) versus total adrenalectomy. Surg Clin N Am 2004; 84: 743–753.
20. Diner EK, Franks ME, Behari A et al. Partial adrenalectomy: The National
Cancer Institute experience. Urology 2005; 66: 19–23.
21. Walther MM, Herring J, Choyke P et al. Laparoscopic partial adrenalec-
tomy in patients with hereditary forms of pheochromocytoma. J Urolog
2000; 164: 14–17.
22. Bravo EL. Pheochromocytoma: new concepts and future trends. Kidney
Int 1991; 40: 544–551.
23. Kebebew E, Siperstein AE, Clark OH et al. Results of laparoscopic adre-
nalectomy for suspected and unsuspected malignant adrenal neoplasms.
Arch Surg 2002; 137: 948–953.
24. Kasperlik-Załuska AA, Otto M, Cichocki A et al. Incidentally discovered
adrenal tumors: a lesson from observation of 1444 patients. Horm Metab
Res 2008; 40: 338–341.
25. Kasperlik-Załuska AA, Otto M, Cichocki A et al. 1,161 patients with adre-
nal incidentalomas: indications for surgery. Langenbecks Arch Surg 2008;
2: 121–126.
26. Sturgeon C, Kebebew E. Laparoscopic adrenalectomy for malignancy.
Surg Clin N Am 2004; 84: 755–774.
27. Tsurn N, Suzuki K, Ushiyama T et al. Laparoscopic adrenalectomy for
large adrenal tumors. J Endourol 2005; 19: 537–540.
28. Gumbs AA, Gagner M. Laparoscopic adrenalectomy. Best Pract Res Clin
Endocrinol Metab 2006; 20: 483–499.
29. Parnaby CN, Chong PS, Chisholm L et al. The role of laparoscopic adre-
nalectomy for adrenal tumors of 6 cm or greater. Surg Endosc 2008; 22:
617–621.
30. Caoili EM, Korobkin V, Francis R. Adrenal masses: characterization with
combined unenhanced and delayed enhanced CT. Radiology 2002; 222:
629–633.
31. Linos DA, Stylopoulos N. How accurate is computed tomography in pre-
dicting the real size of adrenal tumors? A retrospective study. Arch Surg
1977; 132: 740–743.
32. Lau H, Lo CY, Lam KY. Surgical implications of underestimation of
adrenal tumour size by computed tomography. Br J Surg 1999; 96:
385–387.
33. Tai CK, Li SK, Hou SM et al. Laparoscopic adrenalectomy: Comparison
of lateral transperitoneal and lateral retroperitoneal approaches. Surg La-
parosc Endosc Percutan Tech 2006; 16: 141–145.
34. Rubinstein M, Gill IS, Aron M. Prospective randomized comparison of
transperitoneal versus retroperitoneal laparoscopic adrenalectomy. J Urol
2005; 174: 442–445.
35. Lombardi CP, Raffaelli M, De Crea C et al.Role of laparoscopy in the ma-
nagement of adrenal malignancies. J Surg Oncol. 2006; 1: 128–131.
36. Barnett CC, Varma DG, El-Naggar AK. Limitation of size as a criterion in
the evaluation of adrenal tumors. Surgery 2000; 128: 973–982.
